SkelRegen’s New CEO Has Been There Since Company’s Founding


SkelRegen LLC has a new leader. The West Chester, Pa.-based company has appointed Todd F. La Neve, J.D., as CEO, replacing Stephen R. La Neve, who will serve as co-founder and board director.
Involved since the inception of SkelRegen, Todd La Neve brings more than 20 years’ experience in providing strategic direction and growth for businesses. He also is a founding member of Circularis LLC, a consulting firm focused on business improvement and optimization in healthcare and other companies. As SkelRegen CEO, Todd La Neve will focus on developing small molecule tissue regeneration technology for clinical trials.

Former SkelRegen CEO Steve La Neve recently was appointed CEO of ETEX Corporation, a Cambridge, Mass.-based developer and manufacturer of bioresorbable bone substitute materials. He has more than 30 years of experience in the healthcare industry.

“Todd’s experience has always been a valued asset to SkelRegen, and we are pleased now to have him officially in the role of CEO,” said Scott D. Boden, M.D., SkelRegen’s co-founder and chief medical and technology officer.

Boden will continue in his role as co-founder and chief medical, science and technology officer. Boden is a tenured professor of orthopedic surgery at the Emory University School of Medicine in Atlanta, Ga., and serves as the director of the Emory Orthopaedics & Spine Center, vice chairman of orthopedics, CMO/CQO of The Emory University Orthopaedics & Spine Hospital, and Emory Healthcare physician director of strategy and development for orthopedics and spine programs. He also is clinical director of the Whitesides Orthopaedic Research Laboratory. John M. Wozney, Ph.D., will remain SkelRegen’s director of scientific affairs and co-owner.

SkelRegen was founded in September 2012. The company was the first to identify multiple small molecules that are osteoinductive and target different aspects of the skeletal tissue formation pathway, executives claim.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters